Spiperone - An Overview
No adverse consequences on embryo-fetal development were being observed in Expecting rabbits treated orally with doses approximately one hundred mg/kg/day elafibranor, which created systemic exposures (blended AUC for elafibranor and GFT1007) through the period of organogenesis that were fewer than the human publicity. Administration of 300 mg/kg/w